Crispr Therapeutics shares owned by Allianz Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Allianz Asset Management
from 13F filings
Historical chart of Allianz Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Allianz Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $960k | 15k | 62.60 |
2023-09-30 | $637k | 14k | 45.39 |
2023-06-30 | $3.1M | 56k | 56.14 |
2023-03-31 | $2.4M | 54k | 45.23 |
2022-12-31 | $2.1M | 51k | 40.65 |
2022-09-30 | $3.7M | 50k | 72.73 |
2022-06-30 | $1.6M | 27k | 60.00 |
2022-03-31 | $1.7M | 27k | 62.76 |
2021-12-31 | $3.3M | 43k | 75.78 |
2021-09-30 | $4.7M | 42k | 111.91 |
2021-06-30 | $11M | 66k | 161.88 |
2021-03-31 | $3.1M | 26k | 121.84 |
2020-12-31 | $3.4M | 22k | 153.11 |
2020-03-31 | $3.5M | 82k | 42.41 |
2019-12-31 | $2.1M | 34k | 60.92 |
2019-09-30 | $1.6M | 40k | 40.98 |
2019-06-30 | $2.8M | 60k | 47.09 |
2019-03-31 | $2.8M | 80k | 35.72 |
2018-12-31 | $1.8M | 62k | 28.56 |
2018-09-30 | $2.7M | 60k | 44.35 |
2018-06-30 | $7.4M | 126k | 58.76 |
2018-03-31 | $11M | 233k | 45.71 |
2017-12-31 | $5.4M | 232k | 23.48 |
2017-09-30 | $2.4M | 133k | 17.87 |